OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis	185
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis	161
Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity	157
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility	139
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice	121
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice	117
Advanced hydrogel material for colorectal cancer treatment	109
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model	91
Immunomodulatory nano-preparations for rheumatoid arthritis	81
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis	76
Alginate-based aerogels as wound dressings for efficient bacterial capture and enhanced antibacterial photodynamic therapy	68
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment	62
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery	60
Recent progress in nanotechnology-based drug carriers for resveratrol delivery	55
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation	52
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems	52
Effect of pH-sensitive nanoparticles on inhibiting oral biofilms	50
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques	50
Thermo-sensitive self-assembly of poly(ethylene imine)/(phenylthio) acetic acid ion pair in surfactant solutions	50
Effect and mechanism of paclitaxel loaded on magnetic Fe ₃ O ₄ @mSiO ₂ -NH ₂	46
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions	45
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics	45
Correction	45
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats	45
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements	43

Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach	43
Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis	43
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer	42
Nanoparticles-based anti-aging treatment of Alzheimer’s disease	42
Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption	42
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin	40
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases	40
SREKA-targeted liposomes for highly metastatic breast cancer therapy	39
Advance in placenta drug delivery: concern for placenta-originated disease therapy	39
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments	38
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers	38
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management	38
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs	38
Platinum-based drugs and hydrogel: a promising anti-tumor combination	38